Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria

Vaccine

Volumn 30, Issue 48, 2012, Pages 6759-6765

  Giwa, F J ^a   Olayinka, A T ^a   Ogunshola, F T ^b  

^a AHMADU BELLO UNIVERSITY   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Immunisation; Northern Nigeria; Poliomyelitis; Seroprevalence; Zaria

Indexed keywords

NEUTRALIZING ANTIBODY; POLIOMYELITIS VACCINE; POLIOMYELITIS VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; CAREGIVER; CHILD; EDUCATIONAL STATUS; FEMALE; GOVERNMENT; HEALTH STATUS; HUMAN; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; NIGERIA; PARENT; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROPREVALENCE; SEROTYPE; SOCIAL STATUS; VACCINATION;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENDEMIC DISEASES; FEMALE; HUMANS; INFANT; MALE; NIGERIA; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINES; SEROEPIDEMIOLOGIC STUDIES; VACCINATION;

EID: 84868211425     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.09.023     Document Type: Article

References (30)

1. Global Polio Eradication Initiative Bull WHO 2008, 84(August (8)). Available at www.scielosp.org [retrieved January 2010].
2. Wild poliovirus weekly update. Available at: [retrieved March 2010]. http://www.polioeradication.org/casecount.asp.
3. CDC Progress towards interruption of wild polio virus transmission - Worldwide, January 2011-March 2012. Morb Mortal Wkly Rep 2012, 61(May (19)):353-357.
4. CDC Progress towards poliomyelitis eradication - Nigeria. January 2002-March 2003. Morb Mortal Wkly Rep 2003, 52:567-570.
5. Alyward R.B., Hull H.F., Cochi S.L., Sutter R.W., Olivé J.M., Melgaard B. Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull WHO 2000, 78(3):285-907.
6. CDC Progress towards poliomyelitis eradication - Nigeria. January 2008-July 2009. Morb Mortal Wkly Rep 2009, 58(41):1150-1154.
7. WHO Advisory Committee on polio eradication-standing recommendations for responding to circulating polioviruses in polio-free areas. Wkly Epidemiol Rec 2005, 80:330-331.
8. World Health Organisation. Global case count - the Global polio eradication initiative; 2006. Available at http://www.polioeradication.org/casecount.asp.
9. Ian Lewis New bivalent polio vaccine simplifies logistics in hard to reach areas. UNICEF supply division. Available at: [24.02.10]. http://www.technet21.org/forumv3/viewtopic.php.
10. Progress towards poliomyelitis eradication. Nigeria, January 2010-June 2011. Morb Mortal Wkly Rep 2011, 60(31):1053-1057.
11. World Health Organization Executive Board Poliomyelitis: intensification of the global eradication initiative 2012, World Health Organization, Geneva, Switzerland, Available at: http://apps.who.int/gb/ebwha/pdf_files/eb130/b130_r10-en.pdf.
12. UNICEF The Game changer. UNICEF Quarterly Newsletter on Polio Eradication Initiative in Nigeria June 2012, p. 8-9.
13. Cooke J.G., Tahar F. Polio in Nigeria; the race to eradication February 2012, A Report of the Centre for Strategic and International Studies Global Health Policy Centre, p. 15.
14. Baba M.M., Haruna B.A., Ogunmola O., Ambe J.P., Shidali N.N., Oderinde B., et al. A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria. J Med Virol 2012, 84(4):691-696.
15. Aminu M. The epidemiological survey of the level and significance of antibodies to poliomyelitis virus. An unpublished M.Sc. thesis. Ahmadu Bello University, Zaria, Nigeria; 1999. p. 64.
16. World Health Organization Manual for the virological investigation of polio 1997, WHO EPI/GEN/97.01.EP1.
17. El-Sayed N., Al Jorf S., Hennesay K.A., Salama M., Watkins M.A., Abdelwahab J.A. Survey of poliovirus antibodies during the final stage of polio eradication in Egypt. Vaccine 2007, 25:5062-5070.
18. Farag M.K., Al-Mazrou Y.Y., Al Jefry M., Al-Shehri S.N., Baldo M.H., Farghali M. National immunization coverage survey, Saudi Arabia. J Trop Pediatr 1991, 41(1):59-67.
19. Caceres V.M., Sutter R.W. Sabin monovalent OPV vaccines. Review of past experiences and their potential use after polio eradication. Clin Infect Dis 2001, 33:533-541.
20. Grassly N.C., Fraser C., Wenger J., Deshpanda J.M., Sutter R.W., Heyman D.L., et al. New strategies for the eradication of polio India. Science 2006, 314:1150-1153.
21. Wassilak S., Ali Pate M., Wannemuehler K., Jenks J., Burns C., Chenoweth P., et al. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis 2011, 203(7):898-909.
22. Kew O.M., Sutter R.W., de Gourville E.M., Dowdle W.R., Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 2005, 59:587-635.
23. Rakoto-Andrianarivelo M., Gumede N., Jegouic S. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis 2008, 197:1427-1435.
24. Kew O.M., Morris-Glasgow V., Landaverde M. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002, 296:356-359.
25. Elisha R. Perspectives on polio an immunization in Northern Nigeria. Soc Sci Med 2006, 63:1857-1869.
26. Obadare E. A crisis of trust: history, politics, religion and the polio controversy in Northern Nigeria. Patterns Prejudice 2005, 39(3):265-284.
27. US Embassy, Abuja, October Sitrep on Nigerian Polio Eradication Efforts, cable; October 29, 2008. http://wikileaks.ch/cable/2008/10/08ABUJA%202129.htm%23.
28. Olusanya B. Polio vaccination boycott in Nigeria. Lancet 2004, 363:1912.
29. Abdullahi vs Pfizer. Inc. 01 C1v.8118 (WHP). United States District Court for the Southern District of New York, 2005 U. S. Dist. (LEXIS) 16126; August 9, 2005.
30. William J.O., David-West T.S. Poliovirus antibody in children from a paediatric hospital in Ibadan, Nigeria. Rev Rom Virol 1990, 41:129-133.